All Stories

Pfizer shakes up R&D presence in San Diego with $255M site sale, 56 layoffs

Pfizer shakes up R&D presence in San Diego with $255M s...

Apr 10, 2025 0

The company is moving its oncology R&D digs in San Diego to a nearby site, but 5...

From ADCs to radiopharma: How AstraZeneca is trying to 'redefine oncology care'

From ADCs to radiopharma: How AstraZeneca is trying to ...

Apr 10, 2025 0

AstraZeneca has been busy in recent years picking up a shopping list of assets a...

Fierce Biotech Layoff Tracker 2025: Opthea reduces workforce by 65%; Organon lays off 93 staffers

Fierce Biotech Layoff Tracker 2025: Opthea reduces work...

Apr 10, 2025 0

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Alzheon Alzheimer's drug knocked down in pivotal APOLLO...

Apr 10, 2025 0

Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...

Alzheon's Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Alzheon's Alzheimer's drug knocked down in pivotal APOL...

Apr 10, 2025 0

Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...

Alzheon’s Alzheimer’s drug knocked down in pivotal APOLLOE4 bout

Alzheon’s Alzheimer’s drug knocked down in pivotal APOL...

Apr 10, 2025 0

Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...

Fierce Biotech Fundraising Tracker '25: Merida debuts with $121M; Imbria raises $57M

Fierce Biotech Fundraising Tracker '25: Merida debuts w...

Apr 10, 2025 0

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

Keros considers a sale, strengthens defense against potential activist investors

Keros considers a sale, strengthens defense against pot...

Apr 10, 2025 0

Keros Therapeutics is considering whether it needs to find a buyer, while streng...

Opthea lays off 65% of staff after back-to-back phase 3 eye disease flops

Opthea lays off 65% of staff after back-to-back phase 3...

Apr 10, 2025 0

Opthea’s staff are paying for its clinical failures. Days after back-to-back flo...

Tempest, weathering stormy capital markets, hunts for partners for liver cancer drug

Tempest, weathering stormy capital markets, hunts for p...

Apr 10, 2025 0

Unable to secure additional financing amid a stormy market, Tempest Therapeutics...

Atalanta laces up for clinic after RNA epilepsy candidate suppresses seizures in mice

Atalanta laces up for clinic after RNA epilepsy candida...

Apr 10, 2025 0

Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of ...

Fierce Biotech Layoff Tracker 2025: Tango Tx trims team; Organon lays off 93 staffers

Fierce Biotech Layoff Tracker 2025: Tango Tx trims team...

Apr 9, 2025 0

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Flatiron Health forges pact to use Massive Bio's database for patient recruitment

Flatiron Health forges pact to use Massive Bio's databa...

Apr 9, 2025 0

Oncology health tech firm Flatiron Health will use Massive Bio’s patient databas...

Flatiron Health forges pact to use Massive Bio’s database for patient recruitment

Flatiron Health forges pact to use Massive Bio’s databa...

Apr 9, 2025 0

Oncology health tech firm Flatiron Health will use Massive Bio’s patient databas...

Caris Life Sciences collects $168M to fund tumor test rollouts

Caris Life Sciences collects $168M to fund tumor test r...

Apr 9, 2025 0

Caris' MI Cancer Seek assay, greenlit by the FDA in November, examines 228 tumor...

PacBio to cut headcount, costs in face of tariff headwinds

PacBio to cut headcount, costs in face of tariff headwinds

Apr 9, 2025 0

Looking to get its earnings out early, PacBio posted preliminary revenue estimat...

PacBio to cut headcount, costs amid headwinds from trans-Pacific tariffs

PacBio to cut headcount, costs amid headwinds from tran...

Apr 9, 2025 0

Looking to get its earnings out early, PacBio posted preliminary revenue estimat...

From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’

From ADCs to radiopharma: How AstraZeneca is trying to ...

Apr 9, 2025 0

AstraZeneca has been busy in recent years picking up a shopping list of assets a...

Judge permanently blocks NIH grant caps, prompting HHS appeal

Judge permanently blocks NIH grant caps, prompting HHS ...

Apr 9, 2025 0

On Monday, a federal judge permanently blocked the National Institutes of Health...

Cornell and Northwestern next up for federal funding freeze, jeopardizing health research

Cornell and Northwestern next up for federal funding fr...

Apr 9, 2025 0

The Trump administration’s effort to slash federal funding to universities has f...

Vincerx's final merger attempt collapses, leaving ADC biotech to wind down

Vincerx's final merger attempt collapses, leaving ADC b...

Apr 9, 2025 0

With two attempts to merge with other companies having collapsed, Vincerx Pharma...

Vaccine-probiotic combo prevents, clears bacterial gut infections in mice in antibiotic alternative test

Vaccine-probiotic combo prevents, clears bacterial gut ...

Apr 9, 2025 0

Researchers combined a vaccine and a probiotic supplement to tend the microbial ...

HHS cuts contract spend by 35%, with 334 pacts already terminated

HHS cuts contract spend by 35%, with 334 pacts already ...

Apr 8, 2025 0

In the latest of a string of clawbacks, the Department of Health and Human Servi...

Worldwide Clinical Trials turns to AI company to identify hidden patient subpopulations in big data sets

Worldwide Clinical Trials turns to AI company to identi...

Apr 8, 2025 0

Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to disc...

1
2
3
4
5

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.